Provided by Goodwin Procter LLP
Our globally recognized Life Sciences practice is uniquely positioned to partner with innovators and investors operating in a fast-moving, tech-driven environment. With more than 230 dedicated lawyers across all major life sciences hubs in the US, Europe, and Asia, we work with life sciences companies throughout the corporate lifecycle – from startup and commercial-stage to maturity – as well as investors, banks, and others in the life sciences ecosystem.
We understand the unique challenges life science companies face in securing funding, licensing and safeguarding intellectual property, establishing partnerships, bringing new products to market, opening new revenue streams, and protecting existing product lines. We take a multidisciplinary approach to address clients’ challenges, drawing on our deep expertise across industries – such as technology, healthcare, real estate, and private equity – as well as the full spectrum of relevant practices.
Provided by Chambers
Goodwin is adept at handling a range of corporate matters including strategic partnerships, M&A and public and private financings. The firm is skilled at the handling advice on issues such as new drug approvals and securities disclosure.
Goodwin Procter LLP advised Dren Bio in its definitive agreement with Sanofi, in which Sanofi will acquire DR-0201, a targeted bispecific myeloid cell engager.
Provided by Chambers
Kingsley Taft is co-chair of Goodwin's life sciences group. He advises life sciences businesses at every stage of operation and in a wide range of processes, such as strategic alliances and collaborations, venture financings and company formation.
Kingsley is an exceptional life sciences lawyer. His scientific expertise adds truly unique value on the matters most critical to many companies.
Mitchell Bloom is global chair of Goodwin’s life sciences practice. He advises emerging innovator companies, investment banks and venture capital firms worldwide on capital markets offerings, M&A and venture capital transactions.
Julie Tibbets heads the firm's life sciences regulatory and compliance group. She has extensive experience advising emerging and established life sciences companies on a wide range of development, marketing and enforcement matters.
Provided by Goodwin Procter LLP